IRWD IRONWOOD PHARMACEUTICALS INC

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

IRONWOOD PHARMACEUTICALS INC (IRWD) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q1 2025 earnings press release referenced via exhibit — full financial results contained in the attached exhibit, not in filing body
• Investors should review Exhibit for key metrics: revenue, EPS, and guidance updates for IRWD's GI-focused portfolio

Other IRONWOOD PHARMACEUTICALS INC 8-K Filings

8-K Mar 11, 2026

Get deeper insights on IRONWOOD PHARMACEUTICALS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.